Atrial fibrillation
Conditions
Interventions
Patients scheduled to participate in this study will be randomly assigned in a 1:1 ratio to either the FARAPULSE group or the PulseSelect group by using a computer-based system (UMIN INDICE) based on
Sponsors
AONUMA KAZUTAKA
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: -Patients aged 18 years or older -Patients scheduled to undergo pulsed field ablation (PFA) for atrial fibrillation at participating institutions
Exclusion criteria
Exclusion criteria: -Patients who are unable to provide written informed consent to participate in the study -Patients with a history of prior pulmonary vein isolation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| -Comparison of the incidence of intravascular hemolysis between the FARAPULSE and PulseSelect systems -Comparison of the pulmonary vein isolation area (lesion extent) after the initial pulsed field ablation between the FARAPULSE and PulseSelect systems | — |
Secondary
| Measure | Time frame |
|---|---|
| -Exploratory analyses of factors associated with intravascular hemolysis (e.g., number of applications, age, sex, body size, left atrial volume), and investigation of the relationship between intravascular hemolysis and postoperative left atrial function. -Comparison of the proportion of pulmonary veins requiring additional ablation (reapplication of energy), total procedure time (from puncture to completion), and the incidence of adverse events (e.g., cardiac tamponade, phrenic nerve palsy). | — |
Contacts
Public ContactMami Narita
Mito Saiseikai General Hospital
Outcome results
None listed